GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant
Clinical trial NCT02360111 · TERMINATED
Trial details
- NCT number
- NCT02360111
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2017-09-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.